Most people with lupus have skin problems, like rashes or sores. Sometimes lupus affects only the skin, and sometimes it affects other parts of the body, too. How long a rash lasts can vary from ...

Most people with lupus have it affect the skin. The types of rashes can be divided into two large groups. First, when lupus affects the skin with problems only seen in lupus, it’s called cutaneous ...

This autoimmune disease may impact your skin as well as your nails and hair. Learn what to look for to treat lupus more effectively.

Lucille, a 57 years old high school physical education coach, started experiencing a rash on her cheeks and nose. The rash worsened every time she went outside. She had been suffering from joint pain ...

The Lupus Research Alliance applauds the decision by the U.S. Food and Drug Administration (FDA) to grant Breakthrough Therapy designation for litifilimab (BIIB059) in clinical development by Biogen ...

Please provide your email address to receive an email when new articles are posted on . Patients with systemic lupus with a history of skin rashes are likely to have high interferon levels. This ...

Litifilimab is a humanized IgG1 monoclonal antibody targeting the BDCA2 receptor to reduce proinflammatory mediators in cutaneous lupus erythematosus.

Three patients in the UK have received a 'groundbreaking' treatment for lupus, including Katie Tinkler, who received the treatment at University College London Hospital in London. (PA) A new ...

A marijuana-like compound holds out promise as a new treatment for a severe autoimmune skin disease called skin lupus, according to a study published recently by a multicenter team including ...

Imagine your body attacking itself. That’s what happens with lupus, a chronic autoimmune disease affecting millions worldwide. Lupus Alert Day is a chance to shine a spotlight on this condition. It’s ...

SEEING RESULTS. IT’S A MARVEL OF BIOLOGICAL ENGINEERING. FOR 30 YEARS, DOCTOR ROBERTO CARICO, A RHEUMATOLOGIST AT UMASS CHAN MEDICAL SCHOOL, AND HIS PATIENTS HAVE BEEN FIGHTING AN INDOMITABLE OPPONENT ...